Needle-Free epinephrine film could transform emergency allergy care for kids

NCT ID NCT07703982

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests a new dissolving film called DESF that delivers epinephrine under the tongue. It is designed for children ages 7 to 17 who weigh at least 30 kg and have a history of allergic reactions that put them at high risk for severe episodes like anaphylaxis. The goal is to see how the body absorbs the drug, how safe it is, and how well it works compared to standard epinephrine injections. All participants receive a single dose of DESF and are monitored closely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a sublingual epinephrine film called DESF
What this could lead to
If successful, DESF could offer a needle-free way to deliver epinephrine quickly during severe allergic reactions, potentially making emergency treatment easier for children and caregivers.
What could go wrong
This is an early phase 1 study with only 32 children, focused on safety and drug levels, not on treating actual allergic reactions. It may not prove effective or safe enough for wider use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AllerVie Clinical Research

    Birmingham, Alabama, 35209, United States

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Halton Pediatric Allergy

    Burlington, Ontario, L7L 6W6, Canada

  • IAA Clinical Research

    Wheaton, Maryland, 20902, United States

  • J. Lewis Research Inc. / Foothill Family Clinic South

    Salt Lake City, Utah, 84121, United States

  • Rochester Regional Health AIR

    Rochester, New York, 14607, United States

  • Texas Children's Hospital - Feigin Center

    Houston, Texas, 77030, United States

  • UCLA Pediatric Allergy & Immunology

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.